Lepu Biopharma jumps most in 12 weeks on progress of cancer drug application

Lepu Biopharma

27/09/2024 04:58

** Shares of Lepu Biopharma Co Ltd  2157.HK  jump 9.8% to
HK$3.47, on track for the biggest one-day pct rise since July 5 
    ** Stock hit the highest since Aug. 5, extending gains for
third consecutive session 
    ** Lepu said China National Medical Products Administration
issued an acceptance notice of the firm's application for drug
candidate MRG003 to treat recurrent or metastatic nasopharyngeal
cancer
    ** "In the future, the company will fully promote the
commercialisation of MRG003, which will have a positive impact
on the operating results and further enhance the competitiveness
of the company" - Lepu 
    ** Hang Seng Commerce & Industry Index  .HSNC  surges 4.9%,
healthcare index  .HSCIH  jumps 7.1% and Hang Seng Index  .HSI 
rises 3.6%
    ** Stock down 24.9% YTD  

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))